News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Conference News AHA 2018 PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure Michael O'Riordan November 11, 2018
News Conference News AHA 2018 DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors Todd Neale November 10, 2018
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Conference News CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin Michael O'Riordan March 16, 2018